Newsfeeds Archive - Page 101 of 211

1 minute read

Amedisys Names Scott Ginn Acting Chief Operating Officer

November 22, 6:15 PM

Amedisys, Inc. (NASDAQ:AMED), a leading provider of home health, hospice, personal care and high-acuity care, names Scott Ginn, Executive Vice President and Chief Financial Officer, its Acting Chief Operating

AMED

1 minute read

Biolase Files For Offering Of Units Each Consisting Of One Share Of Common Stock, Warrant To Purchase One Share Of Common Stock

By Michael Horton

November 22, 6:02 PM

-SEC Filing

BIOL

3 minute read

News

MDU Resources Announces Five-Year Capital Investment Plan

By Michael Horton

November 22, 5:56 PM

MDU Resources Group, Inc. (NYSE:MDU) today announced its plans to make capital investments totaling $3.5 billion over the five-year period from 2023 to 2027. "Our capital investment plan includes a

MDU

1 minute read

U.S. Treasury Department Issues New Guidance On Implementation Of Price Cap Policy For Russian Crude

By Michael Horton

November 22, 5:52 PM

-Reuters

RSX

2 minute read

FDA
News

Blueprint Medicines Submits Supplemental New Drug Application To FDA For AYVAKIT For Treatment Of Indolent Systemic Mastocytosis

By Michael Horton

November 22, 5:39 PM

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the submission of a supplemental new drug application to the U.S. Food and Drug Administration (FDA) for AYVAKIT® (avapritinib) for the treatment of adults with indolent systemic mastocytosis (SM).

BPMC

1 minute read

News
SEC

SEC Says To Settle Charges Goldman Sachs Asset Management Agreed To Pay $4M Penalty

By Michael Horton

November 22, 5:11 PM

-Reuters

2 minute read

News

Aytu BioPharma Receives 180-Day Extension By Nasdaq To Regain Compliance With Bid Price Rule

By Michael Horton

November 22, 5:08 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription drugs and cost-effective consumer

AYTU

1 minute read

VNET Group Sees FY22 Revenue RMB7.25B-RMB7.55B, Adj. EBITDA RMB1.8B-1.95B

By Michael Horton

November 22, 5:07 PM

Business Outlook The Company expects net revenues for the full year of 2022 to be in the range of RMB7,250 million to RMB7,550 million, and adjusted EBITDA to be in the range of RMB1,800 million to RMB1,950

VNET

1 minute read

Trading Ideas

Top 15 Trending Stocks On WallStreetBets As Of Tuesday, Nov. 22, 2022 (Via Swaggy Stocks)

By Michael Horton

November 22, 2:33 PM

Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment Tesla (TSLA) Zoom Video Communications (ZM) GameStop (GME) Walt Disney (DIS) Apple (AAPL) Amazon (AMZN) Meta Platforms

AAPL

1 minute read

Agora Sees FY22 Revenue $160M-$162M Vs $166.27M Est.

By Michael Horton

November 21, 7:02 PM

Financial Outlook Based on currently available information, Agora has adjusted the previous guidance and now expects that total revenues for the fiscal year ending December 31, 2022 are estimated to be

API